1,720,981 research outputs found

    The Amyloid-β Pathway in Alzheimer’s Disease

    Full text link
    Breakthroughs in molecular medicine have positioned the amyloid-β (Aβ) pathway at the center of Alzheimer's disease (AD) pathophysiology. While the detailed molecular mechanisms of the pathway and the spatial-temporal dynamics leading to synaptic failure, neurodegeneration, and clinical onset are still under intense investigation, the established biochemical alterations of the Aβ cycle remain the core biological hallmark of AD and are promising targets for the development of disease-modifying therapies. Here, we systematically review and update the vast state-of-the-art literature of Aβ science with evidence from basic research studies to human genetic and multi-modal biomarker investigations, which supports a crucial role of Aβ pathway dyshomeostasis in AD pathophysiological dynamics. We discuss the evidence highlighting a differentiated interaction of distinct Aβ species with other AD-related biological mechanisms, such as tau-mediated, neuroimmune and inflammatory changes, as well as a neurochemical imbalance. Through the lens of the latest development of multimodal in vivo biomarkers of AD, this cross-disciplinary review examines the compelling hypothesis- and data-driven rationale for Aβ-targeting therapeutic strategies in development for the early treatment of AD

    VASCULAR AND INFLAMMATORY BLOOD BIOMARKERS OF COGNITIVE IMPAIRMENT AND DEMENTIA

    No full text
    Ph.DDOCTOR OF PHILOSOPHY (SOM

    SINgapore GERiatric intervention study to reduce physical frailty and cognitive decline (SINGER)–pilot: A feasibility study

    No full text
    10.1002/trc2.12141Alzheimer's and Dementia: Translational Research and Clinical Interventions71e12141

    INTERMITTENT FASTING MODULATES EPIGENETIC PATTERNS IN ANIMAL MODELS OF VASCULAR DEMENTIA

    No full text
    Ph.DDOCTOR OF PHILOSOPHY (NUSGS
    corecore